Italian myelofibrosis expert Dr. Giovanni Barosi, discusses the tests that aid in diagnosis of mylofibrosis and prognosis for treatment. He also explains how the Jak-2 V617F mutation is useful in helping to diagnose the condition. Barosi elaborates on various types of clinical follow-up used to monitor patients including cell counts,… Continue reading
Myelofibrosis control tissues in the spleens of patients with this disorder might sustain difference programs equivalent to those located in normal hematopoietic control tissues, based on research outcomes.
The researchers carried out the study to establish the effects of innate qualities of and regulating alerts supplied by the microenvironment in… Continue reading
Things are changing in myelofibrosis. As researchers better understand the genetics of the condition, they are working to develop new drugs to reduce or eliminate side affects of the illness and treat the underlying condition in a patient’s blood cell factory, the bone marrow. A leading scientist and clinician in… Continue reading
I have been on the drug Minipress (prazosin hydrochloride) for an unrelated problem for many years. It is commonly used as a blood pressure medication, but this is not what it was prescribed for in my case. It is known that it can cause white cell counts to go down,… Continue reading
There are several possible causes for a high white blood cell count. This count is high when there are more disease-fighting cells in your body. The technical term for this condition is leukocytosis.
Different medical practices may have different limits by which they define high white blood cell count. A… Continue reading
This seminar, presented to the California Institute for Regenerative Medicine governing board on January 17th, 2012, provides a glimpse into a future of personalized medicine in which genomics, the study of genes and their function, is applied to pinpoint specific treatments for patients. Speakers include Catriona Jamieson, director for stem… Continue reading
This seminar, presented to the California Institute for Regenerative Medicine governing board on January 17th, 2012, provides a glimpse into a future of personalized medicine in which genomics, the study of genes and their function, is applied to pinpoint specific treatments for patients. Speakers included Craig Venter, president and founder… Continue reading
Four minute excerpt from the Spotlight on Genomics seminar presentation during the January 17th 2012 California Institute for Regnerative Medicine governing board meeting. The video features a conversation between Catriona Jamieson, director for stem cell research at UCSD Moores Cancer Center, and one of her patients who is participating in… Continue reading
Give your child an umbrella of health with stem cell banking
In last decade Stem cell transplant in India has gain momentum to cure life threatening diseases. Many cancerous diseases like acute myeloid leukemia, acute lymphatic leukemia, myelodysplastic syndromes, myelofibrosis etc or non cancerous diseases like thalassemia, aplastic anemia, sickle… Continue reading